BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35841309)

  • 21. Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group.
    Pasqualini C; Furtwängler R; van Tinteren H; Teixeira RAP; Acha T; Howell L; Vujanic G; Godzinski J; Melchior P; Smets AM; Coulomb-L'Hermine A; Brisse H; Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Graf N; Verschuur AC
    Eur J Cancer; 2020 Mar; 128():38-46. PubMed ID: 32109849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
    Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
    Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.
    John R; Kurian JJ; Sen S; Gupta MK; Jehangir S; Mathew LG; Mathai J
    J Pediatr Urol; 2018 Dec; 14(6):547.e1-547.e7. PubMed ID: 30017606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience.
    Wilde JC; Aronson DC; Sznajder B; Van Tinteren H; Powis M; Okoye B; Cecchetto G; Audry G; Fuchs J; Schweinitz DV; Heij H; Graf N; Bergeron C; Pritchard-Jones K; Van Den Heuvel-Eibrink M; Carli M; Oldenburger F; Sandstedt B; De Kraker J; Godzinski J
    Pediatr Blood Cancer; 2014 Dec; 61(12):2175-9. PubMed ID: 25156758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies (2001-2020).
    D'Hooghe E; Furtwängler R; Chowdhury T; Vokuhl C; Al-Saadi R; Pritchard-Jones K; Graf N; Vujanić GM
    Cancer; 2023 Jun; 129(12):1930-1938. PubMed ID: 36929497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumor: the experience of the pediatric unit of Kasr El-Aini center of radiation oncology and nuclear medicine (NEMROCK).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2005 Dec; 17(4):308-14. PubMed ID: 17102824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group.
    Ehrlich PF; Ferrer FA; Ritchey ML; Anderson JR; Green DM; Grundy PE; Dome JS; Kalapurakal JA; Perlman EJ; Shamberger RC
    Ann Surg; 2009 Oct; 250(4):642-8. PubMed ID: 19730241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary approach to Wilms' tumor: 18 years of experience.
    Yildiz I; Yüksel L; Ozkan A; Apak H; Celkan T; Danismend N; Büyükünal C; Söylet Y; Sarimurat N; Dervisoglu S; Aksoy F; Atkovar G; Okkan S
    Jpn J Clin Oncol; 2000 Jan; 30(1):17-20. PubMed ID: 10770563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of patients with Wilms' tumour stage III due to positive resection margins only: An analysis of patients treated on the SIOP-WT-2001 protocol in the UK-CCLG and GPOH studies.
    Vujanić GM; Graf N; D'Hooghe E; Chowdhury T; Vokuhl C; Al-Saadi R; Pritchard-Jones K; Melchior P; Furtwängler R
    Int J Cancer; 2023 Apr; 152(8):1640-1647. PubMed ID: 36444500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience.
    Verschuur AC; Vujanic GM; Van Tinteren H; Jones KP; de Kraker J; Sandstedt B
    Pediatr Blood Cancer; 2010 Aug; 55(2):233-8. PubMed ID: 20582946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival.
    Flentje M; Weirich A; Graf N; Pötter R; Zimmerman H; Ludwig R
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):163-9. PubMed ID: 9422573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical aspects in the treatment of patients with unilateral wilms tumor: a report from the SIOP 93-01/German Society of Pediatric Oncology and Hematology.
    Fuchs J; Kienecker K; Furtwängler R; Warmann SW; Bürger D; Thürhoff JW; Hager J; Graf N
    Ann Surg; 2009 Apr; 249(4):666-71. PubMed ID: 19300220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved survival of children with wilms tumor.
    Kutluk T; Varan A; Büyükpamukçu N; Atahan L; Cağlar M; Akyüz C; Büyükpamukçu M
    J Pediatr Hematol Oncol; 2006 Jul; 28(7):423-6. PubMed ID: 16825987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database.
    Saltzman AF; Carrasco A; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
    J Pediatr Urol; 2018 Apr; 14(2):161.e1-161.e8. PubMed ID: 29133167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.
    Fernandez CV; Perlman EJ; Mullen EA; Chi YY; Hamilton TE; Gow KW; Ferrer FA; Barnhart DC; Ehrlich PF; Khanna G; Kalapurakal JA; Bocking T; Huff V; Tian J; Geller JI; Grundy PE; Anderson JR; Dome JS; Shamberger RC
    Ann Surg; 2017 Apr; 265(4):835-840. PubMed ID: 27811504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A long-term follow-up report of pediatric relapsed Wilms tumor after retreatment].
    Wang TY; Pan C; Gao YJ; Hu WT; Ye QD; Zhou M; Tang JY
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):743-747. PubMed ID: 29050111
    [No Abstract]   [Full Text] [Related]  

  • 40. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.